BioCentury | Aug 15, 2019
Company News

Harmony crosses finish line with Wakix for narcolepsy

...the EU. The U.S. biotech also raised a $270 million equity round from investors including Valor Equity Partners...
BioCentury | Oct 13, 2017
Financial News

Harmony raises $270M, licenses narcolepsy drug

...Biosciences LLC (Plymouth Meeting, Pa.) said it raised $270 million in an equity round from Valor Equity Partners...
BioCentury | Oct 6, 2017
Financial News

Harmony raises $270M, licenses narcolepsy drug

...Biosciences LLC (Plymouth Meeting, Pa.) said it raised $270 million in an equity round from Valor Equity Partners...
Items per page:
1 - 3 of 3
BioCentury | Aug 15, 2019
Company News

Harmony crosses finish line with Wakix for narcolepsy

...the EU. The U.S. biotech also raised a $270 million equity round from investors including Valor Equity Partners...
BioCentury | Oct 13, 2017
Financial News

Harmony raises $270M, licenses narcolepsy drug

...Biosciences LLC (Plymouth Meeting, Pa.) said it raised $270 million in an equity round from Valor Equity Partners...
BioCentury | Oct 6, 2017
Financial News

Harmony raises $270M, licenses narcolepsy drug

...Biosciences LLC (Plymouth Meeting, Pa.) said it raised $270 million in an equity round from Valor Equity Partners...
Items per page:
1 - 3 of 3